EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 38 / No 3 (Mars 2022) Med Sci (Paris), 38 3 (2022) 296-302 References
Open Access
Issue
Med Sci (Paris)
Volume 38, Number 3, Mars 2022
Page(s) 296 - 302
Section Repères
DOI https://doi.org/10.1051/medsci/2022025
Published online 25 March 2022
  1. https://www.inserm.fr/information-en-sante/dossiers-information/epigenetique. [Google Scholar]
  2. MarczyloEL. JacobsMN. GantTW. Environmentally induced epigenetic toxicity: potential public health concerns. Crit Rev Toxicol 2016 ; 46 : 676–700. [CrossRef] [PubMed] [Google Scholar]
  3. LagetS. DefossezP-A. Le double jeu de l’épigénétique - Cible et acteur du cancer. Med Sci (Paris) 2008 ; 24 : 725–730. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Bateman S. Médecine personnalisée - Un concept flou, des pratiques diversifiées. Med Sci (Paris) 2014 (hors série n° 2); 30 : 8–13. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  5. Chadwick R. . What’s in a Name? Where’s the Person in Personalized Medicine?. Lato Sensu: Revue De La Société De Philosophie Des Sciences 2018; 4 (2). [Google Scholar]
  6. BillaudM. GuchetX. L’invention de la médecine personnalisée - Entre mutations technologiques et utopie. Med Sci (Paris) 2015 ; 31 : 797–803. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  7. DeltourS. ChopinV. LeprinceD. Modifications épigénétiques et cancer. Med Sci (Paris) 2005 ; 21 : 405–411. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  8. ChengY. HeC. WangM. et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Sig Transduct Target Ther 2019 ; 4 : 1–39. [CrossRef] [Google Scholar]
  9. Baylin SB. Interview with Stephen B Baylin. Epigenomics 2015 ; 7 : 881–883. [CrossRef] [PubMed] [Google Scholar]
  10. Fardi M. Solali S. Farshdousti Hagh M. . Epigenetic mechanisms as a new approach in cancer treatment: An updated review. Genes Dis 2018; 5 : 304–11. [CrossRef] [PubMed] [Google Scholar]
  11. GreeneJA. LoscalzoJ. Putting the Patient Back Together — Social Medicine, Network Medicine, and the Limits of Reductionism. N Engl J Med 2017 ; 377 : 2493–2499. [CrossRef] [PubMed] [Google Scholar]
  12. CharlesMA. DelpierreC. BréantB. Le concept des origines développementales de la santé - Évolution sur trois décennies. Med Sci (Paris) 2016 ; 32 : 15–20. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  13. Beck, S. et Niewöhner, J. Somatographic investigations across levels of complexity. BioSocieties 2006; 1 : 219–27. [CrossRef] [Google Scholar]
  14. BjørklundG. AasethJ. ChirumboloS. et al. Effects of arsenic toxicity beyond epigenetic modifications. Environ Geochem Health 2018 ; 40 : 955–965. [CrossRef] [PubMed] [Google Scholar]
  15. Shinn T. Ragouet P. Formes de division du travail scientifique et convergence intellectuelle. La recherche technico-instrumentale. Revue française de sociologie 2000; 41 : 447–73. [CrossRef] [Google Scholar]
  16. RianchoJ. Del RealA. RianchoJA. How to interpret epigenetic association studies: a guide for clinicians. Bonekey Rep 2016 ; 5 : 797. [PubMed] [Google Scholar]
  17. RakyanVK. DownT. BaldingD. et al. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011 ; 12 : 529–541. [CrossRef] [PubMed] [Google Scholar]
  18. Peerbaye A. Altérations génomiques. Ce que le diagnostic moléculaire fait au cancer. Techniques & Culture. Revue semestrielle d’anthropologie des techniques 2017; 68 : 214–29. [Google Scholar]
  19. PrasadV.. Perspective: The precision-oncology illusion. Nature 2016 ; 537 : S63. [CrossRef] [PubMed] [Google Scholar]
  20. https://www.scientificamerican.com/article/map-of-second-genetic-code-the-epigenome-is-unveiled/. [Google Scholar]
  21. DuprasC. RavitiskyV. Epigenetics in the Neoliberal “Regime of Truth”: A Biopolitical Perspective on Knowledge Translation. Hastings Cent Rep 2016 ; 46 : 26–35. [CrossRef] [PubMed] [Google Scholar]
  22. https://mdxhealth.com/tests/. [Google Scholar]
  23. https://www.fiormarkets.com/report/epigenetics-drugs-diagnostic-technologies-market-by-product-418825.html. [Google Scholar]
  24. Rosier F. Un test sanguin pour détecter un cancer quatre ans avant son diagnostic classique?, Le Monde.fr, 28 juillet 20, https://www.lemonde.fr/sciences/article/2020/07/27/un-test-sanguin-pour-detecter-un-cancer-quatre-ans-avant-son-diagnostic-classique_6047431_1650684.html. [Google Scholar]
  25. Novartis : un médicament contre un cancer validé. Lefigaro.fr, 24 février 2015, https://www.lefigaro.fr/flash-eco/2015/02/24/97002-20150224FILWWW00015-novartis-un-medicament-contre-un-cancer-valide.php. [Google Scholar]
  26. Klingler C. Les promesses des épimédicaments contre les cancers. larecherche.fr, https://www.larecherche.fr/les-promesses-des-%C3%A9pim%C3%A9dicaments-contre-les-cancers. [Google Scholar]
  27. Fuks F. Cancer : vers une thérapie sur mesure. larecherche.fr, https://www.larecherche.fr/cancer-vers-une-th%C3%A9rapie-sur-mesure. [Google Scholar]
  28. FournierT. PoulainJ. La génomique nutritionnelle : (re)penser les liens alimentation-santé à l’articulation des sciences sociales, biomédicales et de la vie. Natures Sciences Sociétés 2017 ; 25 : 111–121. [CrossRef] [EDP Sciences] [Google Scholar]
  29. Silva LBAR, da Cruz RS, Fontelles CC, et al. Maternal and Paternal Nutrition and Developmental Origins of Breast Cancer. In Prates Ong T, Salvador Moreno F (ed). Nutrition and Cancer Prevention: From Molecular Mechanisms to Dietary Recommendations. The Royal Society of Chemistry, 2020 : pp. 207–29. [Google Scholar]
  30. Weiyi J, Tingting X, Cun L, et al. Remodeling the Epigenetic Landscape of Cancer, Application Potential of Flavonoids in the Prevention and Treatment of Cancer. Front Oncol 2021; 11. [Google Scholar]
  31. AroraI. SharmaM. TollefsbolTO. Combinatorial Epigenetics Impact of Polyphenols and Phytochemicals in Cancer Prevention and Therapy. Int J Mol Sci 2019 ; 20 : 4567. [CrossRef] [Google Scholar]
  32. SzicV. SzarcK. et al. From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?. Clin Epigenet 2015 ; 7 : 1–18. [CrossRef] [PubMed] [Google Scholar]
  33. HorvathS.. DNA methylation age of human tissues and cell types. Gen Biol 2013 ; 10 : 1–20. [Google Scholar]
  34. Oblak L, van der Zaag J, Higgins-Chen A, et al. A systematic review of biological, social and environmental factors associated with epigenetic clock acceleration Ageing Res Revs 2021; 69 : 101348. [CrossRef] [Google Scholar]
  35. PernaL. YanZ. UteM. et al. Epigenetic age acceleration predicts cancer, cardiovascular, and all-cause mortality in a German case cohort. Clin Epigenet 2016 ; 8 : 1–7. [CrossRef] [PubMed] [Google Scholar]
  36. https://www.mydnage.com/. [Google Scholar]
  37. https://epi-age.com/product/epiage/. [Google Scholar]
  38. Dupras C, Beck S, Rothstein M, et al. Potential (mis)use of epigenetic age estimators by private companies and public agencies: human rights law should provide ethical guidance. Environmental Epigenetics 2019; 5: dvz018. https://doi.org/10.1093/eep/dvz018. [Google Scholar]
  39. https://foxotechnologies.com/insurance-underwriting/. [Google Scholar]
  40. Kilbride MK, Bradbury AR. Evaluating Web-Based Direct-to-Consumer Genetic Tests for Cancer Susceptibility. JCO Precis Oncol 2020; 4 : PO.19.00317. [PubMed] [Google Scholar]
  41. CassierM. GaudillièreJP. Recherche, médecine et marché : la génétique du cancer du sein. Sciences Sociales et Santé 2000 ; 18 : 29–51. [Google Scholar]
  42. de Rosnay J.. La Symphonie du vivant : Comment l’épigénétique va changer votre vie. Paris: Les liens qui libèrent, 2018 : 240p. [Google Scholar]
  43. Dubois M, Louvel S, Le Goff A, et al. Epigenetics in the public sphere: interdisciplinary perspectives. Environ Epigenet 2019; 5 : dvz019. [CrossRef] [PubMed] [Google Scholar]
  44. https://fouche1820.com/blog/post/17-epigenetique.html. [Google Scholar]
  45. Kelly-Irving M, Delpierre C. The Embodiment Dynamic over the Life Course: A Case for Examining Cancer Aetiology. The Palgrave Handbook of Biology and Society 2018; 519–40. [CrossRef] [Google Scholar]
  46. Park HL. Epigenetic Biomarkers for Environmental Exposures and Personalized Breast Cancer Prevention. Int J Environ Res Public Health 2020; 17 : 1181. [CrossRef] [Google Scholar]
  47. ChiapperinoL. TestaG. The Epigenomic Self in Personalized Medicine: Between Responsibility and Empowerment. The Sociological Review 2017 ; 64 : 203–220. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.